IGC Pharma (IGC) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2025)
IGC Pharma (IGC) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-79.34% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
IGC Pharma |
29.33 Mn |
29.07 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
0.00% |
| Jun 30, 2025 |
33.33% |
| Mar 31, 2025 |
50.00% |
| Dec 31, 2024 |
77.78% |
| Sep 30, 2024 |
60.00% |
| Dec 31, 2017 |
-274.76% |
| Sep 30, 2017 |
50.00% |
| Jun 30, 2017 |
0.00% |
| Mar 31, 2017 |
62.50% |
| Dec 31, 2016 |
73.32% |
| Sep 30, 2016 |
50.00% |
| Jun 30, 2016 |
33.33% |
| Mar 31, 2016 |
11.11% |
| Dec 31, 2015 |
60.00% |
| Sep 30, 2015 |
42.86% |
| Jun 30, 2015 |
75.00% |
| Mar 31, 2015 |
47.06% |
| Dec 31, 2014 |
-25.00% |
| Sep 30, 2014 |
22.22% |
| Jun 30, 2014 |
-33.33% |
